Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies. uri icon

authors

  • Thomas, Miles
  • Kosuri, Satyajit
  • Thirman, Michael J
  • Odenike, Olatoyosi
  • Stock, Wendy
  • Larson, Richard A
  • Madero-Marroquin, Rafael
  • Patel, Anand A
  • Johnston, Hannah
  • Dworkin, Emily
  • Wesevich, Austin
  • Roloff, Gregory W
  • Saygin, Caner
  • Mariam Nawas, MD
  • Drazer, Michael W
  • DuVall, Adam S

publication date

  • October 26, 2025